Back to top

Meet commercial requirements

Navigate an emerging landscape with the mRNA experts

Commercial scale-up of safe and effective mRNA therapeutics demands a reliable supply of raw materials and a dependable manufacturing pipeline. At TriLink, our extensive manufacturing capabilities, stringent quality systems, and a dedicated team of experts ensure the highest level of consistency, purity, and transparency, positioning your product for commercial success and minimizing the risk of adverse effects.

Continuity of supply helps maintain your momentum

Partnering with TriLink secures access to validated, high-quality raw materials to maintain the consistency and safety of your product. By mitigating supply risk, your commercial project can stay on track without compromising its momentum.


GMP-grade CleanCap® technology

Our flagship capping technology is available in GMP-grade to meet any scale of production.


GMP-grade modified uridine nucleosides

The extensive TriLink® catalog of modified nucleoside triphosphates, available from RUO to GMP-grade, provides the highest quality NTPs for any application.

TriLink supports global commercial manufacturing programs, even amid unprecedented demands. Read our case study to learn how we rapidly scaled up production of CleanCap reagent for a leading COVID-19 vaccine.